JP7015243B2 - 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 - Google Patents
吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 Download PDFInfo
- Publication number
- JP7015243B2 JP7015243B2 JP2018548130A JP2018548130A JP7015243B2 JP 7015243 B2 JP7015243 B2 JP 7015243B2 JP 2018548130 A JP2018548130 A JP 2018548130A JP 2018548130 A JP2018548130 A JP 2018548130A JP 7015243 B2 JP7015243 B2 JP 7015243B2
- Authority
- JP
- Japan
- Prior art keywords
- tobacco
- plant
- plants
- modified
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims description 739
- 244000061176 Nicotiana tabacum Species 0.000 title claims description 732
- 230000002829 reductive effect Effects 0.000 title claims description 81
- 235000019505 tobacco product Nutrition 0.000 title claims description 35
- 238000000034 method Methods 0.000 title description 166
- 239000000203 mixture Substances 0.000 title description 18
- 241000196324 Embryophyta Species 0.000 claims description 616
- 102000040430 polynucleotide Human genes 0.000 claims description 184
- 108091033319 polynucleotide Proteins 0.000 claims description 184
- 239000002157 polynucleotide Substances 0.000 claims description 184
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 172
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 170
- 229920001184 polypeptide Polymers 0.000 claims description 169
- 150000007523 nucleic acids Chemical group 0.000 claims description 93
- 230000006870 function Effects 0.000 claims description 73
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 48
- 235000019504 cigarettes Nutrition 0.000 claims description 47
- 108700019146 Transgenes Proteins 0.000 claims description 46
- 102000039446 nucleic acids Human genes 0.000 claims description 43
- 108020004707 nucleic acids Proteins 0.000 claims description 43
- 241000254127 Bemisia tabaci Species 0.000 claims description 37
- 230000002093 peripheral effect Effects 0.000 claims description 34
- 239000000126 substance Substances 0.000 claims description 34
- 241000252254 Catostomidae Species 0.000 claims description 33
- 241000208125 Nicotiana Species 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 24
- 230000009467 reduction Effects 0.000 claims description 23
- 235000019506 cigar Nutrition 0.000 claims description 10
- 239000007937 lozenge Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 description 189
- 230000012010 growth Effects 0.000 description 146
- 230000014509 gene expression Effects 0.000 description 114
- 210000004027 cell Anatomy 0.000 description 101
- 239000013598 vector Substances 0.000 description 101
- 239000002773 nucleotide Substances 0.000 description 81
- 125000003729 nucleotide group Chemical group 0.000 description 80
- 108020004511 Recombinant DNA Proteins 0.000 description 76
- 239000010410 layer Substances 0.000 description 71
- 230000009466 transformation Effects 0.000 description 65
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 63
- 229930192334 Auxin Natural products 0.000 description 61
- 239000002363 auxin Substances 0.000 description 61
- 230000035772 mutation Effects 0.000 description 59
- 210000001519 tissue Anatomy 0.000 description 53
- 239000002679 microRNA Substances 0.000 description 52
- 108700011259 MicroRNAs Proteins 0.000 description 51
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 50
- 239000012634 fragment Substances 0.000 description 49
- 102000004169 proteins and genes Human genes 0.000 description 47
- 235000018102 proteins Nutrition 0.000 description 45
- 108091027963 non-coding RNA Proteins 0.000 description 43
- 102000042567 non-coding RNA Human genes 0.000 description 43
- 108020004414 DNA Proteins 0.000 description 42
- 108091033409 CRISPR Proteins 0.000 description 40
- 230000001105 regulatory effect Effects 0.000 description 35
- 230000015572 biosynthetic process Effects 0.000 description 31
- 102000053187 Glucuronidase Human genes 0.000 description 30
- 108010060309 Glucuronidase Proteins 0.000 description 30
- 230000009368 gene silencing by RNA Effects 0.000 description 27
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical group C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 26
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 26
- 239000000047 product Substances 0.000 description 26
- 101710163270 Nuclease Proteins 0.000 description 25
- 231100000350 mutagenesis Toxicity 0.000 description 25
- 102000014914 Carrier Proteins Human genes 0.000 description 24
- 108010078791 Carrier Proteins Proteins 0.000 description 24
- 230000001939 inductive effect Effects 0.000 description 24
- 239000013612 plasmid Substances 0.000 description 24
- 238000011161 development Methods 0.000 description 23
- 238000010354 CRISPR gene editing Methods 0.000 description 22
- 108010017070 Zinc Finger Nucleases Proteins 0.000 description 22
- 230000018109 developmental process Effects 0.000 description 22
- 238000004519 manufacturing process Methods 0.000 description 22
- 230000002401 inhibitory effect Effects 0.000 description 21
- 238000002703 mutagenesis Methods 0.000 description 21
- 230000001131 transforming effect Effects 0.000 description 21
- 206010021929 Infertility male Diseases 0.000 description 19
- 208000007466 Male Infertility Diseases 0.000 description 19
- 230000005764 inhibitory process Effects 0.000 description 19
- 230000013011 mating Effects 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 239000002609 medium Substances 0.000 description 15
- 230000008569 process Effects 0.000 description 15
- 210000001938 protoplast Anatomy 0.000 description 15
- 230000027455 binding Effects 0.000 description 14
- 238000003776 cleavage reaction Methods 0.000 description 14
- 230000001404 mediated effect Effects 0.000 description 14
- 230000007017 scission Effects 0.000 description 14
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 13
- 238000009395 breeding Methods 0.000 description 13
- 230000030833 cell death Effects 0.000 description 13
- 238000001035 drying Methods 0.000 description 13
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 13
- 229960002715 nicotine Drugs 0.000 description 13
- 241000894007 species Species 0.000 description 13
- 230000033228 biological regulation Effects 0.000 description 12
- 230000001488 breeding effect Effects 0.000 description 12
- 230000001276 controlling effect Effects 0.000 description 12
- 210000000056 organ Anatomy 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 108091026890 Coding region Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 208000037824 growth disorder Diseases 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 11
- 241000589158 Agrobacterium Species 0.000 description 10
- 230000004568 DNA-binding Effects 0.000 description 10
- 102100029796 Protein S100-A10 Human genes 0.000 description 10
- 108010076830 Thionins Proteins 0.000 description 10
- 125000003275 alpha amino acid group Chemical group 0.000 description 10
- 230000001055 chewing effect Effects 0.000 description 10
- 230000000295 complement effect Effects 0.000 description 10
- 238000005520 cutting process Methods 0.000 description 10
- 238000003780 insertion Methods 0.000 description 10
- 230000037431 insertion Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000010186 staining Methods 0.000 description 10
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 10
- 238000013518 transcription Methods 0.000 description 10
- 230000035897 transcription Effects 0.000 description 10
- 108010016529 Bacillus amyloliquefaciens ribonuclease Proteins 0.000 description 9
- 102000053602 DNA Human genes 0.000 description 9
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 9
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 9
- 102000035195 Peptidases Human genes 0.000 description 9
- 108091005804 Peptidases Proteins 0.000 description 9
- 108020004459 Small interfering RNA Proteins 0.000 description 9
- -1 anatabin) Chemical compound 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 239000005090 green fluorescent protein Substances 0.000 description 9
- 239000002243 precursor Substances 0.000 description 9
- 238000013138 pruning Methods 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 230000009261 transgenic effect Effects 0.000 description 9
- 241000219194 Arabidopsis Species 0.000 description 8
- 239000004365 Protease Substances 0.000 description 8
- 108091027981 Response element Proteins 0.000 description 8
- 108010083644 Ribonucleases Proteins 0.000 description 8
- 102000006382 Ribonucleases Human genes 0.000 description 8
- 125000000539 amino acid group Chemical group 0.000 description 8
- 238000003782 apoptosis assay Methods 0.000 description 8
- JKLNYGDWYRKFKR-UHFFFAOYSA-N ethyl methyl sulfate Chemical compound CCOS(=O)(=O)OC JKLNYGDWYRKFKR-UHFFFAOYSA-N 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- 230000005522 programmed cell death Effects 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- 238000011144 upstream manufacturing Methods 0.000 description 8
- 108700028369 Alleles Proteins 0.000 description 7
- 108091032955 Bacterial small RNA Proteins 0.000 description 7
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 7
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 7
- 108091027967 Small hairpin RNA Proteins 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 230000028446 budding cell bud growth Effects 0.000 description 7
- 239000004062 cytokinin Substances 0.000 description 7
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 7
- 238000012217 deletion Methods 0.000 description 7
- 230000037430 deletion Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000010362 genome editing Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000002689 soil Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 241000254173 Coleoptera Species 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 6
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 230000030279 gene silencing Effects 0.000 description 6
- 230000006801 homologous recombination Effects 0.000 description 6
- 238000002744 homologous recombination Methods 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000004055 small Interfering RNA Substances 0.000 description 6
- 230000002103 transcriptional effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 5
- 108020005004 Guide RNA Proteins 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 239000013043 chemical agent Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 239000012636 effector Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 238000011426 transformation method Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 241000219195 Arabidopsis thaliana Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 108020004566 Transfer RNA Proteins 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000007605 air drying Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000004992 fission Effects 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 239000003862 glucocorticoid Substances 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 108091070501 miRNA Proteins 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 230000006780 non-homologous end joining Effects 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 230000010153 self-pollination Effects 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- MYKUKUCHPMASKF-VIFPVBQESA-N (S)-nornicotine Chemical compound C1CCN[C@@H]1C1=CC=CN=C1 MYKUKUCHPMASKF-VIFPVBQESA-N 0.000 description 3
- 101100160772 Arabidopsis thaliana YUC1 gene Proteins 0.000 description 3
- 108091026821 Artificial microRNA Proteins 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 108091079001 CRISPR RNA Proteins 0.000 description 3
- 241001515826 Cassava vein mosaic virus Species 0.000 description 3
- 108010005843 Cysteine Proteases Proteins 0.000 description 3
- 102000005927 Cysteine Proteases Human genes 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 3
- MYKUKUCHPMASKF-UHFFFAOYSA-N Nornicotine Natural products C1CCNC1C1=CC=CN=C1 MYKUKUCHPMASKF-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 101100160773 Oryza sativa subsp. japonica YUCCA1 gene Proteins 0.000 description 3
- 108700001094 Plant Genes Proteins 0.000 description 3
- 239000013614 RNA sample Substances 0.000 description 3
- 108091028664 Ribonucleotide Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 108700009124 Transcription Initiation Site Proteins 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108020000999 Viral RNA Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 230000008436 biogenesis Effects 0.000 description 3
- 230000015709 bud dormancy process Effects 0.000 description 3
- 239000004927 clay Substances 0.000 description 3
- 230000001143 conditioned effect Effects 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 210000002257 embryonic structure Anatomy 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000012239 gene modification Methods 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 238000007602 hot air drying Methods 0.000 description 3
- 238000010884 ion-beam technique Methods 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000000394 mitotic effect Effects 0.000 description 3
- 239000013588 oral product Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 108091007428 primary miRNA Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000002336 ribonucleotide Substances 0.000 description 3
- 125000002652 ribonucleotide group Chemical group 0.000 description 3
- 210000001082 somatic cell Anatomy 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000036435 stunted growth Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 210000003934 vacuole Anatomy 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- MTXSIJUGVMTTMU-JTQLQIEISA-N (S)-anabasine Chemical compound N1CCCC[C@H]1C1=CC=CN=C1 MTXSIJUGVMTTMU-JTQLQIEISA-N 0.000 description 2
- 102100023779 40S ribosomal protein S5 Human genes 0.000 description 2
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108700004850 Arabidopsis BRC1 Proteins 0.000 description 2
- 101100167643 Arabidopsis thaliana CLV3 gene Proteins 0.000 description 2
- 101100259716 Arabidopsis thaliana TAA1 gene Proteins 0.000 description 2
- 241000203069 Archaea Species 0.000 description 2
- 102000035101 Aspartic proteases Human genes 0.000 description 2
- 108091005502 Aspartic proteases Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108010076667 Caspases Proteins 0.000 description 2
- 102000011727 Caspases Human genes 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108091060290 Chromatid Proteins 0.000 description 2
- 230000007018 DNA scission Effects 0.000 description 2
- 101100532389 Gallus gallus RX1 gene Proteins 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 2
- 101000622644 Homo sapiens 40S ribosomal protein S5 Proteins 0.000 description 2
- 101001023359 Homo sapiens Lung adenoma susceptibility protein 2 Proteins 0.000 description 2
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 2
- 101001132674 Homo sapiens Retina and anterior neural fold homeobox protein 2 Proteins 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 108010025815 Kanamycin Kinase Proteins 0.000 description 2
- 102100035138 Lung adenoma susceptibility protein 2 Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 2
- PWHVEHULNLETOV-UHFFFAOYSA-N Nic-1 Natural products C12OC2C2(O)CC=CC(=O)C2(C)C(CCC2=C3)C1C2=CC=C3C(C)C1OC(O)C2(C)OC2(C)C1 PWHVEHULNLETOV-UHFFFAOYSA-N 0.000 description 2
- 241000208134 Nicotiana rustica Species 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 231100000742 Plant toxin Toxicity 0.000 description 2
- 101150083007 RAX1 gene Proteins 0.000 description 2
- 101001023863 Rattus norvegicus Glucocorticoid receptor Proteins 0.000 description 2
- 108700005075 Regulator Genes Proteins 0.000 description 2
- 102100033908 Retina and anterior neural fold homeobox protein 2 Human genes 0.000 description 2
- 108010057163 Ribonuclease III Proteins 0.000 description 2
- 102000003661 Ribonuclease III Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- BFSBNVPBVGFFCF-UHFFFAOYSA-N Tabtoxin Natural products CC(O)C(C(O)=O)NC(=O)C(N)CCC1(O)CNC1=O BFSBNVPBVGFFCF-UHFFFAOYSA-N 0.000 description 2
- 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000004507 artificial chromosome Anatomy 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000010165 autogamy Effects 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000036953 caspase-like activity Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 108010088245 cytokinin oxidase Proteins 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000003208 gene overexpression Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000020169 heat generation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000001114 immunoprecipitation Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000000749 insecticidal effect Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- GWWNCLHJCFNTJA-UHFFFAOYSA-N nicandrenone-2 Natural products C12OC2C2(O)CC=CC(=O)C2(C)C(CCC23C)C1C3CCC2(O)C(C)C1OC(O)C2(C)OC2(C)C1 GWWNCLHJCFNTJA-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 229940023486 oral product Drugs 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 238000003976 plant breeding Methods 0.000 description 2
- 239000003123 plant toxin Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000002708 random mutagenesis Methods 0.000 description 2
- 230000005849 recognition of pollen Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- BFSBNVPBVGFFCF-WDOVLDDZSA-N tabtoxin Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC[C@]1(O)CNC1=O BFSBNVPBVGFFCF-WDOVLDDZSA-N 0.000 description 2
- 108010055631 tabtoxin Proteins 0.000 description 2
- 238000012225 targeting induced local lesions in genomes Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000012250 transgenic expression Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- 229940087195 2,4-dichlorophenoxyacetate Drugs 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- PCGISRHGYLRXSR-UHFFFAOYSA-N 4-hydroxy-7-[(5-hydroxy-7-sulfonaphthalen-2-yl)carbamoylamino]naphthalene-2-sulfonic acid Chemical compound OC1=CC(S(O)(=O)=O)=CC2=CC(NC(=O)NC=3C=C4C=C(C=C(C4=CC=3)O)S(O)(=O)=O)=CC=C21 PCGISRHGYLRXSR-UHFFFAOYSA-N 0.000 description 1
- 101150014069 AMI1 gene Proteins 0.000 description 1
- 108090000104 Actin-related protein 3 Proteins 0.000 description 1
- 102100036826 Aldehyde oxidase Human genes 0.000 description 1
- 101710131969 Aldehyde oxidase 1 Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 240000001436 Antirrhinum majus Species 0.000 description 1
- 108700039610 Arabidopsis STM Proteins 0.000 description 1
- 101100490806 Arabidopsis thaliana AAO1 gene Proteins 0.000 description 1
- 101100167641 Arabidopsis thaliana CLV1 gene Proteins 0.000 description 1
- 101100167642 Arabidopsis thaliana CLV2 gene Proteins 0.000 description 1
- 101100129499 Arabidopsis thaliana MAX2 gene Proteins 0.000 description 1
- 102000008682 Argonaute Proteins Human genes 0.000 description 1
- 108010088141 Argonaute Proteins Proteins 0.000 description 1
- BHELIUBJHYAEDK-OAIUPTLZSA-N Aspoxicillin Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1 BHELIUBJHYAEDK-OAIUPTLZSA-N 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 241001544485 Cordulegastridae Species 0.000 description 1
- FMGBNISRFNDECK-CZSBRECXSA-N Coronatine Chemical compound CC[C@H]1C[C@]1(C(O)=O)NC(=O)C1=C[C@H](CC)C[C@@H]2C(=O)CC[C@H]12 FMGBNISRFNDECK-CZSBRECXSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 102100023266 Dual specificity mitogen-activated protein kinase kinase 2 Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 239000005976 Ethephon Substances 0.000 description 1
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 229940123611 Genome editing Drugs 0.000 description 1
- 241000482313 Globodera ellingtonae Species 0.000 description 1
- 101150021904 HMGB1 gene Proteins 0.000 description 1
- 235000015842 Hesperis Nutrition 0.000 description 1
- 241000081543 Hesperis Species 0.000 description 1
- 101000780650 Homo sapiens Protein argonaute-1 Proteins 0.000 description 1
- 101100235061 Hordeum vulgare HVA1 gene Proteins 0.000 description 1
- 101100396051 Hordeum vulgare HVA22 gene Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 101150089445 Las gene Proteins 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 108010068353 MAP Kinase Kinase 2 Proteins 0.000 description 1
- 241001503485 Mammuthus Species 0.000 description 1
- 101000763602 Manilkara zapota Thaumatin-like protein 1 Proteins 0.000 description 1
- 101000763586 Manilkara zapota Thaumatin-like protein 1a Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108091030146 MiRBase Proteins 0.000 description 1
- 101000966653 Musa acuminata Glucan endo-1,3-beta-glucosidase Proteins 0.000 description 1
- 102000005591 NIMA-Interacting Peptidylprolyl Isomerase Human genes 0.000 description 1
- 108010059419 NIMA-Interacting Peptidylprolyl Isomerase Proteins 0.000 description 1
- 101100327480 Nicotiana tabacum CET2 gene Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 101100259832 Oryza sativa subsp. japonica TAR2 gene Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102100034183 Protein argonaute-1 Human genes 0.000 description 1
- 241000589615 Pseudomonas syringae Species 0.000 description 1
- 101150116803 RAX gene Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 108090000621 Ribonuclease P Proteins 0.000 description 1
- 102000004167 Ribonuclease P Human genes 0.000 description 1
- 101150076721 STIG1 gene Proteins 0.000 description 1
- 101100206899 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TIR2 gene Proteins 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- 235000002560 Solanum lycopersicum Nutrition 0.000 description 1
- 101000953909 Streptomyces viridifaciens Isobutylamine N-hydroxylase Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 102100024554 Tetranectin Human genes 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 108010015382 Tryptophan transaminase Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 101150077913 VIP3 gene Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000005006 adaptive immune system Anatomy 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229930014345 anabasine Natural products 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229930192500 bigelovii Natural products 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 108700021031 cdc Genes Proteins 0.000 description 1
- ICZOIXFFVKYXOM-YCLOEFEOSA-M cefamandole nafate Chemical compound [Na+].CN1N=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)[C@H](OC=O)C=3C=CC=CC=3)[C@H]2SC1 ICZOIXFFVKYXOM-YCLOEFEOSA-M 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000000701 chemical imaging Methods 0.000 description 1
- 239000012707 chemical precursor Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000011509 clonal analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- FMGBNISRFNDECK-UHFFFAOYSA-N coronatine Natural products CCC1CC1(C(O)=O)NC(=O)C1=CC(CC)CC2C(=O)CCC12 FMGBNISRFNDECK-UHFFFAOYSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 208000013175 decreased sucking Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 230000005782 double-strand break Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000005489 dwarf bean Nutrition 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 108010026638 endodeoxyribonuclease FokI Proteins 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 244000037666 field crops Species 0.000 description 1
- 230000008124 floral development Effects 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 108091008915 immune receptors Proteins 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 108010056100 indole-3-acetamide hydrolase Proteins 0.000 description 1
- 239000003617 indole-3-acetic acid Substances 0.000 description 1
- 108010079535 indoleacetamide hydrolase Proteins 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000021005 inheritance pattern Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 108091007426 microRNA precursor Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- YHZJJCDLDGYDKK-GUBZILKMSA-N phaseolotoxin Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNP(N)(=N)NS(O)(=O)=O YHZJJCDLDGYDKK-GUBZILKMSA-N 0.000 description 1
- QDAOSMKOZCCWLJ-UHFFFAOYSA-N phaseolotoxin Natural products NC(N)=NCCCCC(C(O)=O)NC(=O)C(C)NC(=O)C(N)CCCNP(N)(=O)NS(O)(=O)=O QDAOSMKOZCCWLJ-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001691 photoregulatory effect Effects 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 239000000276 potassium ferrocyanide Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 108090000446 ribonuclease T(2) Proteins 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000000682 scanning probe acoustic microscopy Methods 0.000 description 1
- 239000013545 self-assembled monolayer Substances 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- YEENEYXBHNNNGV-XEHWZWQGSA-M sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoate;(2r,3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound [Na+].CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I.O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YEENEYXBHNNNGV-XEHWZWQGSA-M 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 101150065461 tabA gene Proteins 0.000 description 1
- 101150049158 tblA gene Proteins 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 description 1
- 230000001331 thermoregulatory effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000012090 tissue culture technique Methods 0.000 description 1
- 230000030968 tissue homeostasis Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical compound BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
- C12N15/827—Flower development or morphology, e.g. flowering promoting factor [FPF]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022007548A JP7459150B2 (ja) | 2016-03-11 | 2022-01-21 | 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307035P | 2016-03-11 | 2016-03-11 | |
| US62/307,035 | 2016-03-11 | ||
| US201662399181P | 2016-09-23 | 2016-09-23 | |
| US62/399,181 | 2016-09-23 | ||
| PCT/US2017/022156 WO2017156535A1 (en) | 2016-03-11 | 2017-03-13 | Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022007548A Division JP7459150B2 (ja) | 2016-03-11 | 2022-01-21 | 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019512247A JP2019512247A (ja) | 2019-05-16 |
| JP2019512247A5 JP2019512247A5 (enExample) | 2020-04-23 |
| JP7015243B2 true JP7015243B2 (ja) | 2022-02-02 |
Family
ID=58448614
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548130A Active JP7015243B2 (ja) | 2016-03-11 | 2017-03-13 | 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 |
| JP2022007548A Active JP7459150B2 (ja) | 2016-03-11 | 2022-01-21 | 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022007548A Active JP7459150B2 (ja) | 2016-03-11 | 2022-01-21 | 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US10731173B2 (enExample) |
| EP (1) | EP3426786A1 (enExample) |
| JP (2) | JP7015243B2 (enExample) |
| CN (4) | CN117089525A (enExample) |
| WO (1) | WO2017156535A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117089525A (zh) | 2016-03-11 | 2023-11-21 | 奥驰亚客户服务有限公司 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
| WO2017195906A1 (ja) * | 2016-05-13 | 2017-11-16 | 株式会社カネカ | 植物のゲノム編集方法 |
| US11499158B2 (en) | 2016-05-13 | 2022-11-15 | Kaneka Corporation | Method for modifying plant |
| WO2017195905A1 (ja) | 2016-05-13 | 2017-11-16 | 株式会社カネカ | 形質転換植物の作製方法 |
| WO2019051232A1 (en) * | 2017-09-11 | 2019-03-14 | Altria Client Services Llc | COMPOSITIONS AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING REDUCED OR ELIMINATED GOURMETS |
| WO2019084148A1 (en) * | 2017-10-25 | 2019-05-02 | Monsanto Technology Llc | TARGETED RNA GUIDED ENDONUCLEASE ENDONUCLEASE ACTIVITY IN EUKARYOTES |
| EP3830275A1 (en) | 2018-08-02 | 2021-06-09 | Altria Client Services LLC | Optimized tissue-preferred promoter and uses thereof |
| EP3975694A1 (en) * | 2019-05-29 | 2022-04-06 | Altria Client Services LLC | Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers |
| US20240218386A1 (en) * | 2019-12-03 | 2024-07-04 | Altria Client Services Llc | Compositions and Methods for Producing Tobacco Plants and Products Having Altered Alkaloid Levels |
| CN111560389B (zh) * | 2020-06-11 | 2022-07-01 | 云南中烟工业有限责任公司 | 烟草丝裂原活化蛋白激酶基因NtMAPK8及其应用 |
| CN112522308B (zh) * | 2020-12-15 | 2022-04-01 | 山东农业大学 | 拟南芥tir2基因在提高植物盐胁迫抗性中的应用 |
| CN113393174A (zh) * | 2021-07-22 | 2021-09-14 | 浙江中烟工业有限责任公司 | 一种基于关键指标调查测量的烟叶生产过程跟踪方法及其应用 |
| CN113278729B (zh) * | 2021-07-26 | 2021-10-01 | 广东省农业科学院作物研究所 | 一种烟草青枯病的snp分子标记、其获得方法及其应用 |
| US20250086782A1 (en) * | 2023-09-07 | 2025-03-13 | Altria Client Services Llc | Methods of tobacco classification via hyperspectral imaging |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006035221A2 (en) | 2004-09-29 | 2006-04-06 | Advanced Technologies (Cambridge) Limited | Modification of plant development and morphology |
| CN1824774A (zh) | 2004-11-12 | 2006-08-30 | 贾朝钧 | 一种打顶后无腋芽烟草的培育方法 |
| CN104086637A (zh) | 2014-07-04 | 2014-10-08 | 西南大学 | 烟草独脚金内酯转运蛋白NtPDR6及其干扰表达载体和应用 |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US76269A (en) * | 1868-03-31 | oscab taber | ||
| US4091823A (en) | 1976-07-12 | 1978-05-30 | Liggett Group Inc. | Cyclogeraniol and derivatives thereof as tobacco flavorants |
| US4762785A (en) | 1982-08-12 | 1988-08-09 | Calgene, Inc. | Novel method and compositions for introducting alien DNA in vivo |
| US4528993A (en) | 1982-08-20 | 1985-07-16 | R. J. Reynolds Tobacco Company | Process for producing moist snuff |
| US4660577A (en) | 1982-08-20 | 1987-04-28 | R.J. Reynolds Tobacco Company | Dry pre-mix for moist snuff |
| US4516590A (en) | 1982-11-26 | 1985-05-14 | Philip Morris Incorporated | Air-cured bright tobacco filler, blends and smoking articles |
| NL8300698A (nl) | 1983-02-24 | 1984-09-17 | Univ Leiden | Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten. |
| US4732856A (en) | 1984-04-03 | 1988-03-22 | Carnegie Institution Of Washington | Transposable elements and process for using same |
| US5231019A (en) | 1984-05-11 | 1993-07-27 | Ciba-Geigy Corporation | Transformation of hereditary material of plants |
| US5149645A (en) | 1984-06-04 | 1992-09-22 | Rijksuniversiteit Leiden | Process for introducing foreign DNA into the genome of plants |
| US4678904A (en) | 1984-07-06 | 1987-07-07 | Technology Dynamics, Inc. | Optical measuring device using a spectral modulation sensor having an optically resonant structure |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4638816A (en) | 1985-03-22 | 1987-01-27 | Philip Morris Incorporated | Smoking compositions containing a glycosylamine flavorant additive |
| US5188958A (en) | 1986-05-29 | 1993-02-23 | Calgene, Inc. | Transformation and foreign gene expression in brassica species |
| US5177010A (en) | 1986-06-30 | 1993-01-05 | University Of Toledo | Process for transforming corn and the products thereof |
| SE455438B (sv) | 1986-11-24 | 1988-07-11 | Aga Ab | Sett att senka en brennares flamtemperatur samt brennare med munstycken for oxygen resp brensle |
| US5004863B2 (en) | 1986-12-03 | 2000-10-17 | Agracetus | Genetic engineering of cotton plants and lines |
| US4848373A (en) | 1987-04-13 | 1989-07-18 | Helme Tobacco Company | Nicotine removal process and product produced thereby |
| US5316931A (en) | 1988-02-26 | 1994-05-31 | Biosource Genetics Corp. | Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes |
| US5085325A (en) | 1988-03-08 | 1992-02-04 | Simco/Ramic Corporation | Color sorting system and method |
| US5013658A (en) | 1988-05-13 | 1991-05-07 | Dna Plant Technology Corporation | Transposon tagging of genes in transformed plants |
| US5990387A (en) | 1988-06-10 | 1999-11-23 | Pioneer Hi-Bred International, Inc. | Stable transformation of plant cells |
| US4987907A (en) | 1988-06-29 | 1991-01-29 | Helme Tobacco Company | Chewing tobacco composition and process for producing same |
| US5879918A (en) | 1989-05-12 | 1999-03-09 | Pioneer Hi-Bred International, Inc. | Pretreatment of microprojectiles prior to using in a particle gun |
| US5141131A (en) | 1989-06-30 | 1992-08-25 | Dowelanco | Method and apparatus for the acceleration of a propellable matter |
| US5932782A (en) | 1990-11-14 | 1999-08-03 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species adhered to microprojectiles |
| US5372149A (en) | 1992-03-25 | 1994-12-13 | Roth; David S. | Sterilization process in the manufacturing of snuff |
| EP0652965A1 (en) | 1992-07-27 | 1995-05-17 | Pioneer Hi-Bred International, Inc. | An improved method of agrobacterium-mediated transformation of cultured soybean cells |
| IL108241A (en) | 1992-12-30 | 2000-08-13 | Biosource Genetics Corp | Plant expression system comprising a defective tobamovirus replicon integrated into the plant chromosome and a helper virus |
| US5469976A (en) | 1993-04-30 | 1995-11-28 | Burchell; James R. | Shelf allocation and management system |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| US5789156A (en) | 1993-06-14 | 1998-08-04 | Basf Ag | Tetracycline-regulated transcriptional inhibitors |
| KR100386337B1 (ko) | 1993-12-09 | 2004-03-24 | 토마스 제퍼슨 대학교 | 진핵세포에서부위-특이적돌연변이를위한화합물과그방법 |
| US5491081A (en) | 1994-01-26 | 1996-02-13 | Pioneer Hi-Bred International, Inc. | Soybean cyst nematode resistant soybeans and methods of breeding and identifying resistant plants |
| US5659026A (en) | 1995-03-24 | 1997-08-19 | Pioneer Hi-Bred International | ALS3 promoter |
| US5689035A (en) | 1995-09-26 | 1997-11-18 | Pioneer Hi-Bred International, Inc. | Brown stem rot resistance in soybeans |
| US5760012A (en) | 1996-05-01 | 1998-06-02 | Thomas Jefferson University | Methods and compounds for curing diseases caused by mutations |
| US5731181A (en) | 1996-06-17 | 1998-03-24 | Thomas Jefferson University | Chimeric mutational vectors having non-natural nucleotides |
| US6072050A (en) | 1996-06-11 | 2000-06-06 | Pioneer Hi-Bred International, Inc. | Synthetic promoters |
| DE19631255A1 (de) | 1996-08-02 | 1998-02-05 | Amazonen Werke Dreyer H | Rüttelegge |
| US5880330A (en) * | 1996-08-07 | 1999-03-09 | The Salk Institute For Biological Studies | Shoot meristem specific promoter sequences |
| US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
| EP0979311A1 (en) | 1997-04-30 | 2000-02-16 | Of The University Of Minnesota Regents | $i(IN VIVO) USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES |
| EP1007712A4 (en) | 1997-08-05 | 2004-06-30 | Kimeragen Inc | USE OF DUPLEX OLIGONUCLEOTIDES TO AFFECT LOCAL GENETIC CHANGES IN PLANTS |
| US6615709B1 (en) | 1997-11-17 | 2003-09-09 | Metso Paper, Inc. | Method for detecting contamination and/or damaging of a face that runs through a nip or nips in a calendar for paper |
| US6410872B2 (en) | 1999-03-26 | 2002-06-25 | Key Technology, Inc. | Agricultural article inspection apparatus and method employing spectral manipulation to enhance detection contrast ratio |
| WO2000058035A1 (en) | 1999-03-29 | 2000-10-05 | Src Vision, Inc. | Multi-band spectral sorting system for light-weight articles |
| EP1318406B1 (de) | 2001-12-04 | 2005-11-09 | B.R.A.H.M.S Aktiengesellschaft | Verwendung der Glycin-N-Acyl-Transferase (GNAT) für die Diagnose von Entzündungserkrankungen und Sepsis |
| US6930492B2 (en) | 2002-08-29 | 2005-08-16 | Malcam Ltd. | Using surface microwaves for measuring and determining density and/or moisture content of a material |
| US7025066B2 (en) | 2002-10-31 | 2006-04-11 | Jerry Wayne Lawson | Method of reducing the sucrose ester concentration of a tobacco mixture |
| US20040118422A1 (en) | 2002-12-19 | 2004-06-24 | Swedish Match North Europe Ab | Tobacco dough and a method for its manufacture |
| US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
| US7694686B2 (en) | 2003-12-22 | 2010-04-13 | U.S. Smokeless Tobacco Company | Conditioning process for tobacco and/or snuff compositions |
| US20060200878A1 (en) | 2004-12-21 | 2006-09-07 | Linda Lutfiyya | Recombinant DNA constructs and methods for controlling gene expression |
| EP1851317B1 (en) | 2005-02-23 | 2011-10-26 | North Carolina State University | Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| US8301890B2 (en) | 2006-08-10 | 2012-10-30 | Inside Secure | Software execution randomization |
| EP3378953A1 (en) | 2006-10-12 | 2018-09-26 | Monsanto Technology LLC | Plant micrornas and methods of use thereof |
| US8319011B2 (en) | 2006-12-15 | 2012-11-27 | U.S. Smokeless Tobacco Company Llc | Tobacco plants having reduced nicotine demethylase activity |
| BRPI0820042B1 (pt) | 2007-11-12 | 2020-05-19 | North Carolina State University | método de obtenção de uma planta de tabaco, ou célula ou parte desta, tendo níveis reduzidos de nornicotina, produto de tabaco, método para fabricar um produto de tabaco, polinucleotídeo isolado, cassete de expressão, polipetpídeo isolado e método de obtenção de uma planta, ou parte de planta desta, do gênero nicotiana |
| ES2351009B1 (es) * | 2009-01-13 | 2012-01-23 | Consejo Superior De Investigaciones Científicas (Csic) | Genes reguladores de la ramificación de plantas, promotores, construcciones genéticas que los contienen y usos. |
| WO2011027315A1 (en) | 2009-09-04 | 2011-03-10 | Moshe Danny S | Grading of agricultural products via hyper spectral imaging and analysis |
| PH12012501393B1 (en) | 2010-01-15 | 2017-10-25 | Univ North Carolina State | Compositions and methods for minimizing nornicotine synthesis in tobacco |
| JP6693747B2 (ja) * | 2012-12-21 | 2020-05-13 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 植物体中のたばこ特異的ニトロソアミンの低減 |
| CN113652416A (zh) | 2014-10-06 | 2021-11-16 | 奥驰亚客户服务有限公司 | 烟草植物中腋芽生长的遗传控制 |
| CN117089525A (zh) | 2016-03-11 | 2023-11-21 | 奥驰亚客户服务有限公司 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
| CN108247740B (zh) | 2018-01-21 | 2019-07-23 | 成都冠佳科技有限公司 | 无刀痕泡棉胶模切生产方法 |
-
2017
- 2017-03-13 CN CN202310851781.4A patent/CN117089525A/zh active Pending
- 2017-03-13 EP EP17714332.8A patent/EP3426786A1/en not_active Withdrawn
- 2017-03-13 CN CN202310853662.2A patent/CN117126815A/zh active Pending
- 2017-03-13 US US15/457,553 patent/US10731173B2/en active Active
- 2017-03-13 WO PCT/US2017/022156 patent/WO2017156535A1/en not_active Ceased
- 2017-03-13 JP JP2018548130A patent/JP7015243B2/ja active Active
- 2017-03-13 CN CN201780028908.5A patent/CN109715810B/zh active Active
- 2017-03-13 CN CN202310852150.4A patent/CN117089526A/zh active Pending
-
2020
- 2020-06-23 US US16/908,891 patent/US11807860B2/en active Active
-
2022
- 2022-01-21 JP JP2022007548A patent/JP7459150B2/ja active Active
-
2023
- 2023-09-28 US US18/476,495 patent/US12209249B2/en active Active
-
2024
- 2024-12-18 US US18/985,344 patent/US20250129379A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006035221A2 (en) | 2004-09-29 | 2006-04-06 | Advanced Technologies (Cambridge) Limited | Modification of plant development and morphology |
| CN1824774A (zh) | 2004-11-12 | 2006-08-30 | 贾朝钧 | 一种打顶后无腋芽烟草的培育方法 |
| CN104086637A (zh) | 2014-07-04 | 2014-10-08 | 西南大学 | 烟草独脚金内酯转运蛋白NtPDR6及其干扰表达载体和应用 |
Non-Patent Citations (1)
| Title |
|---|
| African Journal of Biotechnology，2012年02月23日，Vol.11, No.16，pp.3919-3927 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117089525A (zh) | 2023-11-21 |
| US10731173B2 (en) | 2020-08-04 |
| CN109715810A (zh) | 2019-05-03 |
| US11807860B2 (en) | 2023-11-07 |
| US20240035042A1 (en) | 2024-02-01 |
| CN109715810B (zh) | 2023-07-14 |
| US20170260535A1 (en) | 2017-09-14 |
| JP2022058708A (ja) | 2022-04-12 |
| US20250129379A1 (en) | 2025-04-24 |
| JP2019512247A (ja) | 2019-05-16 |
| US20200318129A1 (en) | 2020-10-08 |
| CN117126815A (zh) | 2023-11-28 |
| WO2017156535A1 (en) | 2017-09-14 |
| CN117089526A (zh) | 2023-11-21 |
| US12209249B2 (en) | 2025-01-28 |
| JP7459150B2 (ja) | 2024-04-01 |
| EP3426786A1 (en) | 2019-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7459150B2 (ja) | 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 | |
| JP7399923B2 (ja) | アルカロイドレベル改変タバコ植物体及び製品を作出する組成物及び方法 | |
| US12129474B2 (en) | Composition and methods for producing tobacco plants and products having reduced tobacco-specific nitrosamines (TSNAs) | |
| JP7479286B2 (ja) | タバコ植物を産生するための組成物および方法、ならびに変化したアルカロイドレベルを有する産物 | |
| US12286637B2 (en) | Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers | |
| CN116171106A (zh) | 用于生产具有改变的生物碱水平的烟草植物和制品的组合物和方法 | |
| WO2018119124A1 (en) | Compositions and methods for producing tobacco plants and products having altered alkaloid levels | |
| CN115516098A (zh) | 与改进的氮利用效率有关的方法和组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20190617 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20190619 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200311 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200311 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210322 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210618 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20210630 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210916 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211222 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220121 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7015243 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |